This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Alexion Joins The International Federation Of Kidney Foundations In Celebrating World Kidney Day 2013

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced its support of World Kidney Day 2013, a global awareness campaign led by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations. Celebrated on the second Thursday in March each year, the mission of World Kidney Day is to raise awareness of the importance of our kidneys to overall health and to reduce the incidence and impact of kidney disease and its associated health problems worldwide. This year’s campaign -“Kidney’s for Life - Stop Kidney Attack!” - aims to educate the general public and the healthcare community about diseases that affect the kidneys and the importance of early detection and intervention. Alexion is pleased to sponsor this initiative and joins other leading companies engaged in researching and delivering innovative therapies to improve the lives of patients suffering from life-threatening disorders, including those that impact the kidneys.

Many health conditions that damage kidney function can severely affect a patient’s quality of life and progress to end-stage renal disease (ESRD) and premature death. One such disease is atypical hemolytic uremic syndrome (aHUS), a chronic, life-threatening ultra-rare disease that can progressively damage vital organs, including the kidney. Patients with aHUS experience kidney damage and kidney failure leading to ESRD. 1 Sixty-five percent of patients with aHUS require kidney dialysis, have permanent kidney damage or die within the first year after diagnosis despite plasma exchange or plasma infusion (PE/PI). 2,3

"At the age of 28, I was experiencing renal failure but my doctors were not able to pinpoint the cause of it,” says Jill Ziegler, a young adult diagnosed with aHUS. “Subsequently, I was diagnosed with a severe and life-threatening condition that is so rare that many nephrologists have never seen a case of it. I tried to maintain some semblance of a normal life with my family, but I remained in end stage kidney failure and on permanent dialysis. Fortunately, I was able to have a kidney transplant and receive a new treatment for aHUS. Today I want others with aHUS to know that help is out there and they are not alone.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs